People living with NASH, patients and families, whose lives and livelihoods are at risk from a liver disease few outside of a small circle of academic and clinical experts had heard of a few years ago have very practical, urgent needs:

1. Disease education/awareness (for patients, providers, payers, policymakers)

2. Development and designation of simplified non-invasive testing and expanded screening (get beyond the biopsy)

3. FDA-approval of NASH drugs, devices, and diagnostics (find a treatment)

4. Clinical environments organized to provide coordinated integrated care to people at every stage of the NAFLD-NASH spectrum

(Washington, DC - June 14, 2022) – The Embassy of Italy, in collaboration with Global Liver Institute (GLI), will host an event on June 14 entitled “From Progress in the Control of Viral Hepatitis to the Rising Epidemic of NASH” for the occasion of International NASH Day, a liver health awareness campaign led annually by GLI in June. The event will feature a scientific presentation highlighting the bilateral efforts to improve liver health in Italy and the United States, with a robust lineup of speakers.